Advertisement

Obesity and Chronic Kidney Disease

      Summary

      This article summarizes the current hypotheses that link visceral obesity and kidney malfunction and provides information on the epidemiology and renal pathology resulting from visceral obesity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Nephrology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Haslam D.W.
        • James W.P.
        Obesity.
        Lancet. 2005; 366: 1197-1209
        • Pereira M.A.
        • Kartashov A.I.
        • Ebbeling C.B.
        • Van Horn L.
        • Slattery M.L.
        • Jacobs Jr, D.R.
        • et al.
        Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis.
        Lancet. 2005; 365: 36-42
        • Yoon K.H.
        • Lee J.H.
        • Kim J.W.
        • Cho J.H.
        • Choi Y.H.
        • Ko S.H.
        • et al.
        Epidemic obesity and type 2 diabetes in Asia.
        Lancet. 2006; 368: 1681-1688
        • Zimmet P.
        • Alberti G.
        • Kaufman F.
        • Tajima N.
        • Silink M.
        • Arslanian S.
        • et al.
        The metabolic syndrome in children and adolescents.
        Lancet. 2007; 369: 2059-2061
        • Kipping R.R.
        • Jago R.
        • Lawlor D.A.
        Obesity in children.
        BMJ. 2008; 337: a1824
        • Olshansky S.J.
        • Passaro D.J.
        • Hershow R.C.
        • Layden J.
        • Carnes B.A.
        • Brody J.
        • et al.
        A potential decline in life expectancy in the United States in the 21st century.
        N Engl J Med. 2005; 352: 1138-1145
        • Mann C.C.
        Public health.
        Science. 2005; 307: 1716-1717
        • Hall J.E.
        • Kuo J.J.
        • da Silva A.A.
        • de Paula R.B.
        • Liu J.
        • Tallam L.
        Obesity-associated hypertension and kidney disease.
        Curr Opin Nephrol Hypertens. 2003; 12: 195-200
        • Henegar J.R.
        • Bigler S.A.
        • Henegar L.K.
        • Tyagi S.C.
        • Hall J.E.
        Functional and structural changes in the kidney in the early stages of obesity.
        J Am Soc Nephrol. 2001; 12: 1211-1217
        • Griffin K.A.
        • Kramer H.
        • Bidani A.K.
        Adverse renal consequences of obesity.
        Am J Physiol Renal Physiol. 2008; 294: F685-F696
        • Tomaszewski M.
        • Charchar F.J.
        • Maric C.
        • McClure J.
        • Crawford L.
        • Grzeszczak W.
        • et al.
        Glomerular hyperfiltration: a new marker of metabolic risk.
        Kidney Int. 2007; 71: 816-821
        • Krikken J.A.
        • Lely A.T.
        • Bakker S.J.
        • Navis G.
        The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men.
        Kidney Int. 2007; 71: 260-265
        • Rook M.
        • Bosma R.J.
        • van Son W.J.
        • Hofker H.S.
        • van der Heide J.J.
        • ter Wee P.M.
        • et al.
        Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors.
        Am J Transplant. 2008; 8: 2077-2085
        • Bosma R.J.
        • Kwakernaak A.J.
        • van der Heide J.J.
        • de Jong P.E.
        • Navis G.J.
        Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact.
        Am J Transplant. 2007; 7: 645-652
        • Chagnac A.
        • Weinstein T.
        • Herman M.
        • Hirsh J.
        • Gafter U.
        • Ori Y.
        The effects of weight loss on renal function in patients with severe obesity.
        J Am Soc Nephrol. 2003; 14: 1480-1486
        • Perrini S.
        • Leonardini A.
        • Laviola L.
        • Giorgino F.
        Biological specificity of visceral adipose tissue and therapeutic intervention.
        Arch Physiol Biochem. 2008; 114: 277-286
        • Phillips L.K.
        • Prins J.B.
        The link between abdominal obesity and the metabolic syndrome.
        Curr Hypertens Rep. 2008; 10: 156-164
        • Bays H.E.
        • Gonzalez-Campoy J.M.
        • Bray G.A.
        • Kitabchi A.E.
        • Bergman D.A.
        • Schorr A.B.
        • et al.
        Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
        Expert Rev Cardiovasc Ther. 2008; 6: 343-368
        • Kim J.Y.
        • van de Wall E.
        • Laplante M.
        • Azzara A.
        • Trujillo M.E.
        • Hofmann S.M.
        • et al.
        Obesity-associated improvements in metabolic profile through expansion of adipose tissue.
        J Clin Invest. 2007; 117: 2621-2637
        • Petersen K.F.
        • Shulman G.I.
        Etiology of insulin resistance.
        Am J Med. 2006; 119: S10-S16
        • Klein S.
        • Fontana L.
        • Young V.L.
        • Coggan A.R.
        • Kilo C.
        • Patterson B.W.
        • et al.
        Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
        N Engl J Med. 2004; 350: 2549-2557
        • Pinto-Sietsma S.J.
        • Navis G.
        • Janssen W.M.
        • de Zeeuw D.
        • Gans R.O.
        • de Jong P.E.
        A central body fat distribution is related to renal function impairment, even in lean subjects.
        Am J Kidney Dis. 2003; 41: 733-741
        • Bonnet F.
        • Marre M.
        • Halimi J.M.
        • Stengel B.
        • Lange C.
        • Laville M.
        • et al.
        Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR study.
        J Hypertens. 2006; 24: 1157-1163
        • Arner P.
        Introduction: the inflammation orchestra in adipose tissue.
        J Intern Med. 2007; 262: 404-407
        • Becker B.
        • Kronenberg F.
        • Kielstein J.T.
        • Haller H.
        • Morath C.
        • Ritz E.
        • et al.
        Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
        J Am Soc Nephrol. 2005; 16: 1091-1098
        • Lastra G.
        • Manrique C.
        • Sowers J.R.
        Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
        Adv Chronic Kidney Dis. 2006; 13: 365-373
        • Rocchini A.P.
        • Katch V.
        • Kveselis D.
        • Moorehead C.
        • Martin M.
        • Lampman R.
        • Gregory M.
        Insulin and renal sodium retention in obese adolescents.
        Hypertension. 1989; 14: 367-374
        • Landsberg L.
        Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
        J Hypertens. 2001; 19: 523-528
        • Sarafidis P.A.
        • Whaley-Connell A.
        • Sowers J.R.
        • Bakris G.L.
        Cardiometabolic syndrome and chronic kidney disease: what is the link?.
        J Cardiometab Syndr. 2006; 1: 58-65
        • Cassis L.A.
        • Police S.B.
        • Yiannikouris F.
        • Thatcher S.E.
        Local adipose tissue renin-angiotensin system.
        Curr Hypertens Rep. 2008; 10: 93-98
        • Vogt B.
        • Bochud M.
        • Burnier M.
        The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
        Semin Nephrol. 2007; 27: 529-537
        • Shibata S.
        • Nagase M.
        • Yoshida S.
        • Kawachi H.
        • Fujita T.
        Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
        Hypertension. 2007; 49: 355-364
        • Ehrhart-Bornstein M.
        • Lamounier-Zepter V.
        • Schraven A.
        • Langenbach J.
        • Willenberg H.S.
        • Barthel A.
        • et al.
        Human adipocytes secrete mineralocorticoid-releasing factors.
        Proc Natl Acad Sci U S A. 2003; 100: 14211-14216
        • Goodfriend T.L.
        • Ball D.L.
        • Egan B.M.
        • Campbell W.B.
        • Nithipatikom K.
        Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion.
        Hypertension. 2004; 43: 358-363
        • Verhave J.C.
        • Hillege H.L.
        • Burgerhof J.G.
        • Janssen W.M.
        • Gansevoort R.T.
        • Navis G.J.
        • et al.
        Sodium intake affects urinary albumin excretion especially in overweight subjects.
        J Intern Med. 2004; 256: 324-330
        • Bello A.K.
        • de Zeeuw D.
        • El Nahas M.
        • Brantsma A.H.
        • Bakker S.J.
        • de Jong P.E.
        • et al.
        Impact of weight change on albuminuria in the general population.
        Nephrol Dial Transplant. 2007; 22: 1619-1627
        • Wolf G.
        • Chen S.
        • Han D.C.
        • Ziyadeh F.N.
        Leptin and renal disease.
        Am J Kidney Dis. 2002; 39: 1-11
        • Sharma K.
        • Ramachandrarao S.
        • Qiu G.
        • Usui H.K.
        • Zhu Y.
        • Dunn S.R.
        • et al.
        Adiponectin regulates albuminuria and podocyte function in mice.
        J Clin Invest. 2008; 118: 1645-1656
        • Sanchez-Lozada L.G.
        • Tapia E.
        • Jimenez A.
        • Bautista P.
        • Cristobal M.
        • Nepomuceno T.
        • et al.
        Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats.
        Am J Physiol Renal Physiol. 2007; 292: F423-F429
        • Elsayed E.F.
        • Tighiouart H.
        • Weiner D.E.
        • Griffith J.
        • Salem D.
        • Levey A.S.
        • et al.
        Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD.
        Am J Kidney Dis. 2008; 52: 49-57
        • Sanches F.M.
        • Avesani C.M.
        • Kamimura M.A.
        • Lemos M.M.
        • Axelsson J.
        • Vasselai P.
        • et al.
        Waist circumference and visceral fat in CKD: a cross-sectional study.
        Am J Kidney Dis. 2008; 52: 66-73
        • Praga M.
        • Hernandez E.
        • Andres A.
        • Leon M.
        • Ruilope L.M.
        • Rodicio J.L.
        Effects of body-weight loss and captopril treatment on proteinuria associated with obesity.
        Nephron. 1995; 70: 35-41
        • Hsu C.Y.
        • McCulloch C.E.
        • Iribarren C.
        • Darbinian J.
        • Go A.S.
        Body mass index and risk for end-stage renal disease.
        Ann Intern Med. 2006; 144: 21-28
        • Wang Y.
        • Chen X.
        • Song Y.
        • Caballero B.
        • Cheskin L.J.
        Association between obesity and kidney disease: a systematic review and meta-analysis.
        Kidney Int. 2008; 73: 19-33
        • Iseki K.
        • Ikemiya Y.
        • Kinjo K.
        • Inoue T.
        • Iseki C.
        • Takishita S.
        Body mass index and the risk of development of end-stage renal disease in a screened cohort.
        Kidney Int. 2004; 65: 1870-1876
        • Kurella M.
        • Lo J.C.
        • Chertow G.M.
        Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
        J Am Soc Nephrol. 2005; 16: 2134-2140
        • Foster M.C.
        • Hwang S.J.
        • Larson M.G.
        • Lichtman J.H.
        • Parikh N.I.
        • Vasan R.S.
        • et al.
        Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.
        Am J Kidney Dis. 2008; 52: 39-48
        • Ryu S.
        • Chang Y.
        • Woo H.Y.
        • Kim S.G.
        • Kim D.I.
        • Kim W.S.
        • et al.
        Changes in body weight predict CKD in healthy men.
        J Am Soc Nephrol. 2008; 19: 1798-1805
        • Young J.A.
        • Hwang S.J.
        • Sarnak M.J.
        • Hoffmann U.
        • Massaro J.M.
        • Levy D.
        • et al.
        Association of visceral and subcutaneous adiposity with kidney function.
        Clin J Am Soc Nephrol. 2008; 3: 1786-1791
        • Iseki K.
        • Tohyama K.
        • Matsumoto T.
        • Nakamura H.
        High prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD).
        Hypertens Res. 2008; 31: 249-255
        • Reeves G.K.
        • Pirie K.
        • Beral V.
        • Green J.
        • Spencer E.
        • Bull D.
        Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.
        BMJ. 2007; 335: 1134
        • Adams K.F.
        • Leitzmann M.F.
        • Albanes D.
        • Kipnis V.
        • Moore S.C.
        • Schatzkin A.
        • et al.
        Body size and renal cell cancer incidence in a large US cohort study.
        Am J Epidemiol. 2008; 168: 268-277
        • Renehan A.G.
        • Tyson M.
        • Egger M.
        • Heller R.F.
        • Zwahlen M.
        Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
        Lancet. 2008; 371: 569-578
        • Obligado S.H.
        • Goldfarb D.S.
        The association of nephrolithiasis with hypertension and obesity: a review.
        Am J Hypertens. 2008; 21: 257-264
        • Nasr S.H.
        • D'Agati V.D.
        • Said S.M.
        • Stokes M.B.
        • Largoza M.V.
        • Radhakrishnan J.
        • et al.
        Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure.
        Clin J Am Soc Nephrol. 2008; 3: 1676-1683
        • Weisinger J.R.
        • Kempson R.L.
        • Eldridge F.L.
        • Swenson R.S.
        The nephrotic syndrome: a complication of massive obesity.
        Ann Intern Med. 1974; 81: 440-447
        • Kambham N.
        • Markowitz G.S.
        • Valeri A.M.
        • Lin J.
        • D'Agati V.D.
        Obesity-related glomerulopathy: an emerging epidemic.
        Kidney Int. 2001; 59: 1498-1509
        • Chen H.M.
        • Liu Z.H.
        • Zeng C.H.
        • Li S.J.
        • Wang Q.W.
        • Li L.S.
        Podocyte lesions in patients with obesity-related glomerulopathy.
        Am J Kidney Dis. 2006; 48: 772-779
        • Serra A.
        • Romero R.
        • Lopez D.
        • Navarro M.
        • Esteve A.
        • Perez N.
        • et al.
        Renal injury in the extremely obese patients with normal renal function.
        Kidney Int. 2008; 73: 947-955
        • Rea D.J.
        • Heimbach J.K.
        • Grande J.P.
        • Textor S.C.
        • Taler S.J.
        • Prieto M.
        • et al.
        Glomerular volume and renal histology in obese and non-obese living kidney donors.
        Kidney Int. 2006; 70: 1636-1641
        • Altiparmak M.R.
        • Pamuk O.N.
        • Pamuk G.E.
        • Apaydin S.
        • Ozbay G.
        Diffuse diabetic glomerulosclerosis in a patient with impaired glucose tolerance: report on a patient who later develops diabetes mellitus.
        Neth J Med. 2002; 60: 260-262
        • Souraty P.
        • Nast C.C.
        • Mehrotra R.
        • Barba L.
        • Martina J.
        • Adler S.G.
        Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetes.
        Nat Clin Pract Nephrol. 2008; 4: 639-642
        • Praga M.
        • Morales E.
        Obesity, proteinuria and progression of renal failure.
        Curr Opin Nephrol Hypertens. 2006; 15: 481-486
        • Praga M.
        • Hernandez E.
        • Herrero J.C.
        • Morales E.
        • Revilla Y.
        • Diaz-Gonzalez R.
        • et al.
        Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy.
        Kidney Int. 2000; 58: 2111-2118
        • Gonzalez E.
        • Gutierrez E.
        • Morales E.
        • Hernandez E.
        • Andres A.
        • Bello I.
        • et al.
        Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney.
        Kidney Int. 2005; 68: 263-270
        • Praga M.
        Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy.
        Nephrol Dial Transplant. 2005; 20: 2594-2597
        • Morales E.
        • Valero M.A.
        • Leon M.
        • Hernandez E.
        • Praga M.
        Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies.
        Am J Kidney Dis. 2003; 41: 319-327
        • Alexander M.P.
        • Patel T.V.
        • Farag Y.M.
        • Florez A.
        • Rennke H.G.
        • Singh A.K.
        Am J Kidney Dis. 2009; 53: 751-759
        • Bonnet F.
        • Deprele C.
        • Sassolas A.
        • Moulin P.
        • Alamartine E.
        • Berthezene F.
        • et al.
        Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.
        Am J Kidney Dis. 2001; 37: 720-727
        • Kaartinen K.
        • Syrjanen J.
        • Porsti I.
        • Harmoinen A.
        • Pasternack A.
        • Huhtala H.
        • et al.
        Insulin resistance and the progression of IgA glomerulonephritis.
        Nephrol Dial Transplant. 2007; 22: 778-783
        • Meier-Kriesche H.U.
        • Arndorfer J.A.
        • Kaplan B.
        The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death.
        Transplantation. 2002; 73: 70-74